PharmaNutra Group is designing a development plan for its US subsidiary with the assistance of a leading international strategic consulting firm
PISA, Italy, Oct. 30, 2024 /CNW/ -- PharmaNutra S.p.A. (MTA; Ticker PHN), specializing in mineral-based nutritional supplements and medical devices for muscles and joints, has signed an agreement with a prominent strategy consulting firm to define the development plan for PharmaNutra USA Corp., its American subsidiary based in Florida, active in the distribution and marketing of the Group's products in the United States.
Read more at newswire.ca